Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 2440-2441, 1997;
This Article
Right arrow Full Text
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Letizia, C.
Right arrow Articles by Clemente, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Letizia, C.
Right arrow Articles by Clemente, G.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:2440-2441.)
© 1997 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Increased Plasma Endothelin-1 After Nicotine Consumption in Nonsmokers

Claudio Letiziaa, Sabrina Cerci, Stefano Subioli, Luigi Scuro and Giovanni Clemente

2nd Dept. of Intern. Med., University of Rome "La Sapienza", Rome, Italy
a Address correspondence to this author, at: 2a Clinica Medica, Policlinico Umberto I, 00185 Rome, Italy.


To the Editor:

Endothelin-1 (ET-1) is a potent vasoconstrictive peptide originally isolated from the supernatant of cultured porcine endothelial cells (1). ET-1 has not only contractile effects but also growth effects on both smooth muscle and heart muscle cells in vitro (2). Studies have shown that some substances (1)(3), e.g., vasopressin (4), stimulate the release of immunoreactive ET-1 from cultured bovine carotid endothelial cells.

Smoking is known to induce a variety of effects in the cardiovascular and hormonal systems in humans (5)(6)(7)(8)(9)(10). Administration of nicotine causes the release of some hormones (9)(10) and produces increases in blood pressure, heart rate, cardiac output, and oxygen consumption (5)(6)(7)(8). Recently, Yildiz et al. (11) reported that heavy cigarette smokers had higher plasma ET-1 concentrations than either light smokers or controls. In another study, Haak et al. (. . . [Full Text of this Article]


References







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.